Johns Hopkins Receives $35M In Funding For COVID-19 Blood Plasma Trials

Johns Hopkins researchers have received over $30 million in funding from the U.S. Department of Defense for two nationwide clinical trials to test the effectiveness of a convalescent blood plasma outpatient treatment.